Application of New Cholesterol Guidelines to the Korean Adult Diabetic Patients

Bu Kyung Kim1, Hyeon Chang Kim2, Kyoung Hwa Ha3

  • 1Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.

Insights

New guidelines significantly expand statin therapy eligibility for Korean diabetic patients. The study highlights a critical gap in current dyslipidemia treatment, urging for guideline development and improved patient care.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines broadened indications for statin therapy for hypercholesterolemia.
  • Current statin therapy use among diabetic patients in Korea for dyslipidemia is suboptimal.

Purpose of the Study:

  • To estimate the number of diabetic patients indicated for statin therapy in Korea using both the Third Adult Treatment Panel (ATP-III) and new ACC/AHA guidelines.
  • To compare the eligibility for statin therapy between the two guideline sets in the Korean diabetic population.

Main Methods:

  • Analysis of data from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
  • Inclusion of diabetic patients aged 30 years and older.
  • Application of ATP-III and ACC/AHA guidelines to assess statin therapy indications.

Main Results:

  • Among 1,598 diabetic patients not on dyslipidemia medication, 65.6% met ATP-III criteria, while 94.3% met the new ACC/AHA criteria.
  • Overall, the new guidelines increased the proportion of eligible diabetic patients for statin therapy from 53.1% to 76.2% compared to ATP-III.
  • Only 19.1% of the total 1,975 diabetic patients were on dyslipidemia medication.

Conclusions:

  • The new ACC/AHA guidelines substantially increase the number of diabetic patients indicated for statin therapy in Korea.
  • A significant gap exists between current statin therapy indications and actual treatment in Korean diabetic patients.
  • Development of specific Korean guidelines and enhanced efforts are needed to ensure appropriate statin therapy for diabetic patients.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
841
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.6K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
419
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339